Pharmaceutical Industry Blog

Last Updated: June 4, 2026 TL;DR: Dicyclomine HCl Injection — a sterile aqueous solution of the anticholinergic antispasmodic dicyclomine (dicycloverine) hydrochloride, supplied most commonly as a 10 mg/mL solution in 2 mL ampoules for intramuscular administration — is a widely used agent for the relief of smooth-muscle spasm in functional gastrointestinal disorders such as irritable bowel syndrome, and in intestinal, biliary and renal colic. As a tertiary-amine antimuscarini

Last Updated: June 4, 2026 TL;DR: Drotaverine HCl Injection — a sterile aqueous solution of the smooth-muscle antispasmodic drotaverine hydrochloride, supplied most commonly as a 40 mg/2 mL (20 mg/mL) solution in amber-glass ampoules for slow intravenous or intramuscular administration — is a widely used agent for the rapid relief of acute smooth-muscle spasm: biliary and renal (ureteric) colic, gastrointestinal and gastric spasm, dysmenorrhoea and spastic pain in obstetric a

Last Updated: June 3, 2026 TL;DR: Fluphenazine Decanoate Injection — a sterile oily depot solution of the long-acting phenothiazine antipsychotic fluphenazine decanoate, supplied most commonly as a 25 mg/mL solution in a sesame-oil or other oily vehicle in 1 mL and 10 mL ampoules and vials for deep intramuscular injection — is a cornerstone of maintenance treatment for schizophrenia and other chronic psychotic disorders. As a decanoate ester dissolved in an oily vehicle, it i

Last Updated: June 3, 2026 TL;DR: Sodium Stibogluconate Injection — a sterile aqueous solution of the pentavalent antimonial antileishmanial sodium stibogluconate, supplied most commonly as a solution containing 100 mg/mL of pentavalent antimony (Sb-V) in multi-dose vials and ampoules for slow intravenous or intramuscular administration — is a first-line agent against leishmaniasis in much of the endemic world: visceral leishmaniasis (kala-azar), cutaneous leishmaniasis and m

Last Updated: June 2, 2026 TL;DR: Ethylmethylhydroxypyridine Succinate Injection — a sterile clear solution of the antioxidant and membrane-protective neuroprotective emoxypine succinate, supplied most commonly as a 50 mg/mL solution in 2 mL and 5 mL ampoules for slow intravenous or intramuscular administration — is widely used in the CIS and allied markets for acute and chronic cerebral circulatory disorders, including the acute phase of ischaemic cerebrovascular accident, d

Last Updated: June 2, 2026 TL;DR: Micafungin for Injection — a sterile lyophilised powder of the echinocandin antifungal micafungin sodium, supplied most commonly as 50 mg and 100 mg vials for reconstitution and dilution before slow intravenous infusion — is a front-line agent for serious invasive fungal disease: invasive candidiasis and candidaemia, oesophageal candidiasis, and prophylaxis of Candida infection in patients undergoing haematopoietic stem-cell transplantation o